Lise Willems Selected Research

Lise Willems Research Topics

Disease

12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 01/2008
11	Neoplasms (Cancer) 04/2023 - 08/2009
7	Lymphoma (Lymphomas) 02/2024 - 01/2018
5	Leukemia 04/2024 - 06/2013
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024 - 03/2016
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 01/2019
3	Infections 01/2022 - 05/2010
2	VEXAS syndrome 01/2024 - 07/2023
2	Hodgkin Disease (Hodgkin's Disease) 01/2024 - 08/2023
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 08/2014
2	COVID-19 11/2022 - 10/2022
2	Multiple Myeloma 10/2022 - 08/2021
2	Febrile Neutropenia 01/2022 - 10/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2019
2	Philadelphia Chromosome 12/2021 - 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2024
1	Hyperkalemia 08/2023
1	Colitis 04/2023
1	Hemorrhage 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 10/2022
1	Myeloid Sarcoma (Chloroma) 11/2021
1	Dermatomyositis (Dermatopolymyositis) 01/2021
1	Vasculitis (Vasculitides) 10/2020
1	Lymphocytosis 01/2019
1	Plasmacytoma 01/2018
1	Anemia 03/2016
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 06/2013
1	Clostridium Infections 08/2012

Drug/Important Bio-Agent (IBA)

5	TOR Serine-Threonine KinasesIBA 11/2013 - 01/2008
5	Mechanistic Target of Rapamycin Complex 1IBA 11/2013 - 01/2008
4	Proteins (Proteins, Gene)FDA Link 03/2016 - 08/2009
3	Rituximab (Mabthera)FDA Link 03/2024 - 01/2018
3	Azacitidine (5 Azacytidine)FDA Link 10/2023 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2023
2	Methotrexate (Mexate)FDA LinkGeneric 02/2024 - 01/2018
2	EnzymesIBA 01/2024 - 07/2023
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2023 - 01/2008
2	Monoclonal AntibodiesIBA 10/2022 - 08/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022 - 01/2019
2	ibrutinibIBA 01/2021 - 01/2019
2	Glutamine (L-Glutamine)FDA Link 09/2015 - 11/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2012 - 11/2010
2	MTOR InhibitorsIBA 04/2012 - 05/2010
2	Sirolimus (Rapamycin)FDA Link 04/2012 - 08/2009
1	RNA Splicing FactorsIBA 04/2024
1	Bendamustine Hydrochloride FDA Link 03/2024
1	CytokinesIBA 01/2024
1	Interleukin-18 (Interleukin 18)IBA 01/2024
1	InflammasomesIBA 01/2024
1	Chemokine ReceptorsIBA 01/2024
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2024
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	Chimeric Antigen ReceptorsIBA 08/2023
1	UbiquitinIBA 07/2023
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2023
1	idelalisibIBA 04/2023
1	Inosine Triphosphate (ITP)IBA 01/2023
1	7- (4'- (2- nitroimidazole- 1- yl)butyl)theophyllineIBA 01/2023
1	VaccinesIBA 11/2022
1	2019-nCoV Vaccine mRNA-1273IBA 11/2022
1	BNT162 VaccineIBA 11/2022
1	Messenger RNA (mRNA)IBA 11/2022
1	COVID-19 VaccinesIBA 10/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	ponatinibIBA 12/2021
1	asciminibIBA 12/2021
1	nelarabine (506U78)FDA Link 11/2021
1	venetoclaxIBA 11/2021
1	eprenetapoptIBA 10/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	AutoantibodiesIBA 01/2021
1	GlucocorticoidsIBA 10/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Phospholipases (Phospholipase)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	Immunomodulating AgentsIBA 01/2018
1	guanosine 5'-monophosphorothioateIBA 01/2017
1	HematinicsIBA 03/2016
1	APG101IBA 03/2016
1	Immunoglobulin G (IgG)IBA 03/2016
1	Thrombopoietin ReceptorsIBA 08/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2014
1	romiplostim FDA Link 08/2014
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	Cytostatic AgentsIBA 04/2012

Therapy/Procedure

13	Therapeutics 10/2022 - 03/2010
6	Drug Therapy (Chemotherapy) 02/2024 - 01/2019
2	Immunotherapy 08/2023 - 10/2022
1	Radiotherapy 01/2024
1	Stem Cell Transplantation 01/2022
1	Drug Tapering 10/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018
1	Heterologous Transplantation (Xenotransplantation) 11/2013
1	Hematopoietic Stem Cell Transplantation 08/2012